Susceptibility of anaerobic flora recovered from complicated intra-abdominal infections to clinafloxacin and imipenem

Anaerobe

Volumn 5, Issue 3-4, 1999, Pages 435-437

  Hopkins, J A ^a   Wilson, S E ^a   Shimabukuro, J ^a   Chavez, C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINAFLOXACIN; IMIPENEM;

ABDOMINAL INFECTION; ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033141290     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1006/anae.1999.0251     Document Type: Conference Paper

References (5)

1. Citron D.M. and Appleman M.D. (1997) Comparative in vitro activities of trovafloxacin (CP-99, 219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infections. Antimicrob Agents Chemother 41: 2312-2316
2. Goldstein E.J.C. and Citron D.M. (1992) Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990 and WIN 57273 against anaerobic bacteria. Antimicrob Agents Chemother 36: 1158-1162
3. Goldstein E.J.C. (1993) Patterns of susceptibility to fluoroquinolones among anaerobic bacterial isolates in the United States. Clin Infect Dis 16 (Suppl. 4): S377-381
4. Hecht D.W. and Wexler H.M. (1996) In vitro susceptibility of anaerobes to quinolones in the United States. Clin Infect Dis 23 (Suppl. 1): S2-8
5. National Committee for Clinical Laboratory Standards (1993) Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 3rd Edn., Approved Standard NCCLS Document M11-A3. NCCLS, Villanova, PA